[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_361 

# __Improved management of liver transplant recipients__

## Articles mentionning this Benefit

* [SARS-CoV-2 in wastewater: potential health risk, but also data source](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_70.md)

## Category to which it belongs

* [Improved outcomes, reduced vulnerability, and enhanced efficiency are achieved through a variety of measures and interventions.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_18.md)

## Description of actual returns pertaining to this benefit

* [Private investors can benefit by ensuring the availability of adequate healthcare facilities and services for liver transplant recipients, which enhances the reputation and demand for healthcare-related properties in the built environment.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_388.md)

## Name of the Benefit

Giving attention to liver transplant recipients with metabolic comorbidities and maintaining their immunosuppression can lead to better management and outcomes for these patients during the COVID-19 pandemic.

## Risks which can benefit from this action

* [Attention to liver transplant recipients with metabolic comorbidities](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_365.md)

## Stakeholders benefitting from this Benefit

* [Liver transplant recipients with metabolic comorbidities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_175.md)

